Last reviewed · How we verify
PRO-087
At a glance
| Generic name | PRO-087 |
|---|---|
| Also known as | chondroitin sulfate + sodium hyaluronate, Humylub PF, humylub preservative-free ophthalmic solution, humylub preservative-free ophthalmic solution PF, humylub preservative-free |
| Sponsor | Laboratorios Sophia S.A de C.V. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PHASE4)
- Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (PHASE4)
- Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRO-087 CI brief — competitive landscape report
- PRO-087 updates RSS · CI watch RSS
- Laboratorios Sophia S.A de C.V. portfolio CI